Show simple item record

dc.creatorTamposis I., Tsougos I., Karatzas A., Vassiou K., Vlychou M., Tzortzis V.en
dc.date.accessioned2023-01-31T10:06:06Z
dc.date.available2023-01-31T10:06:06Z
dc.date.issued2021
dc.identifier10.1055/s-0041-1741481
dc.identifier.issn18690327
dc.identifier.urihttp://hdl.handle.net/11615/79593
dc.description.abstractBackground and Objective Prostate cancer (PCa) is a severe public health issue and the most common cancer worldwide in men. Early diagnosis can lead to early treatment and long-term survival. The addition of the multiparametric magnetic resonance imaging in combination with ultrasound (mpMRI-U/S fusion) biopsy to the existing diagnostic tools improved prostate cancer detection. Use of both tools gradually increases in every day urological practice. Furthermore, advances in the area of information technology and artificial intelligence have led to the development of software platforms able to support clinical diagnosis and decision-making using patient data from personalized medicine. Methods We investigated the current aspects of implementation, architecture, and design of a health care information system able to handle and store a large number of clinical examination data along with medical images, and produce a risk calculator in a seamless and secure manner complying with data security/accuracy and personal data protection directives and standards simultaneously. Furthermore, we took into account interoperability support and connectivity to legacy and other information management systems. The platform was implemented using open source, modern frameworks, and development tools. Results The application showed that software platforms supporting patient follow-up monitoring can be effective, productive, and of extreme value, while at the same time, aiding toward the betterment medicine clinical workflows. Furthermore, it removes access barriers and restrictions to specialized care, especially for rural areas, providing the exchange of medical images and patient data, among hospitals and physicians. Conclusion This platform handles data to estimate the risk of prostate cancer detection using current state-of-the-art in eHealth systems and services while fusing emerging multidisciplinary and intersectoral approaches. This work offers the research community an open architecture framework that encourages the broader adoption of more robust and comprehensive systems in standard clinical practice. © 2022 Georg Thieme Verlag. All rights reserved.en
dc.language.isoenen
dc.sourceApplied Clinical Informaticsen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85123654910&doi=10.1055%2fs-0041-1741481&partnerID=40&md5=28ebf0b87437e0ea8c73b5e16473a762
dc.subjectartificial intelligenceen
dc.subjectdiagnostic imagingen
dc.subjecthumanen
dc.subjectmaleen
dc.subjectpathologyen
dc.subjectpersonalized medicineen
dc.subjectprostateen
dc.subjectprostate tumoren
dc.subjectsoftwareen
dc.subjectArtificial Intelligenceen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectPrecision Medicineen
dc.subjectProstateen
dc.subjectProstatic Neoplasmsen
dc.subjectSoftwareen
dc.subjectGeorg Thieme Verlagen
dc.titlePCaGuard: A Software Platform to Support Optimal Management of Prostate Canceren
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record